Clinical Trials on Potentially Resectable ALK Positive Non-Small Cell Lung Cancer in Spain
Total 802 results
-
PsiOxus Therapeutics LtdCompletedResectable Colon Cancer | Resectable Non-small Cell Lung Cancer | Resectable Bladder Cancer | Resectable Renal Cell CarcinomaSpain
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
MedImmune LLCCompletedStage III Non-small Cell Lung Cancer | UnresectableUnited States, Canada, Italy, Spain, France, Hong Kong, Portugal, Taiwan, Poland
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
Clinica Universidad de Navarra, Universidad de...Highlight TherapeuticsRecruitingNon-Small Cell Lung Cancer MetastaticSpain
-
MedImmune LLCCompletedNSCLC | Resectable | Early-stageUnited States, Canada, Switzerland, Italy, France, Portugal, Spain
-
ETOP IBCSG Partners FoundationHoffmann-La RocheTerminatedNon-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentIreland, Spain, Belgium, Italy, Netherlands, Switzerland
-
Institut Català d'OncologiaInstitut d'Investigació Biomèdica de Bellvitge; Asociación Española contra...RecruitingLung Cancer | Lung Cancer Stage IV | Lung Cancer, Nonsmall Cell, Stage IIIA | Lung Cancer Non-Small Cell Stage IIIB | Lung Cancer Non-Small Cell Stage IIISpain
-
Worldwide Innovative Network AssociationPfizer; ARC Foundation for Cancer ResearchTerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIBIsrael, United States, Luxembourg, Spain
-
Novartis PharmaceuticalsCompletedALK-positive Non-small Cell Lung CancerUnited States, France, Italy, United Kingdom, Taiwan, Turkey, Belgium, Germany, Canada, Singapore, Spain, Korea, Republic of, Netherlands, Russian Federation, Brazil, Hong Kong, Australia
-
Spanish Lung Cancer GroupCompletedNon Small Cell Lung CancerSpain
-
Eli Lilly and CompanyTerminatedNon-Small-Cell Lung CancerSpain
-
Mario Negri Institute for Pharmacological ResearchAstraZeneca; Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoActive, not recruitingNon-small Cell Lung Cancer Stage IIIItaly, Spain, France
-
Spanish Lung Cancer GroupMerck Sharp & Dohme LLCTerminatedNon-small Cell Lung CancerSpain
-
Daiichi SankyoAstraZenecaAvailableAdvanced Non-Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Austria, Spain
-
Galvanize Therapeutics, Inc.Active, not recruitingNon Small Cell Lung CancerHong Kong, Spain, Netherlands
-
Debiopharm International SASyneos HealthTerminatedNon-small Cell Lung CancerSpain, France, United Kingdom
-
ACEA Therapeutics, Inc.TerminatedNon Small Cell Lung CancerUnited States, Spain, France
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerFrance, Korea, Republic of, United Kingdom, Spain
-
Grupo de Investigación y Divulgación OncológicaUnknownNon-small Cell Lung Cancer (NSCLC)Spain
-
Hoffmann-La RocheTerminatedSquamous Non-Small Cell Lung CancerCanada, Spain, Denmark
-
AstraZenecaQuintiles, Inc.CompletedNon Small Cell Lung CancerKorea, Republic of, Spain, France
-
Grupo Gallego de Cancer de PulmonAstraZeneca; Dynamic SolutionsUnknownMetastatic Non-Small-Cell Lung CancerSpain
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lunch CancerItaly, United States, Germany, Spain, Canada
-
Asociación para la Investigación del Cáncer de...Pivotal S.L.Terminated
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationSpain, United States, Korea, Republic of, Taiwan, Italy, Australia, France
-
Samsung Bioepis Co., Ltd.RecruitingNon-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage IIKorea, Republic of, Poland, Spain, Turkey
-
AstraZenecaCompletedEGFR Mutated Non-small Cell Lung Cancer PatientsSpain
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
AstraZenecaTerminatedSquamous Non Small Cell Lung CancerSpain, United States, Germany
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedNon Small Cell Lung CancerAustralia, New Zealand, Spain
-
Spanish Lung Cancer GroupActive, not recruiting
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IVUnited States, Belgium, Bosnia and Herzegovina, Canada, Croatia, Czech Republic, Germany, Poland, Romania, Russian Federation, Serbia, Spain, United Kingdom
-
Mythic TherapeuticsRecruitingNon-Small Cell Lung Cancer | NSCLC | Advanced Non-Small Cell Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB | Advanced Non-Small Cell Squamous Lung Cancer | Advanced Non-Small Cell Non-Squamous Lung CancerUnited States, Australia, Korea, Republic of, United Kingdom, Spain
-
AstraZenecaTerminatedSmall Cell Lung Cancer | Non-Small Cell Lung CancerUnited States, Taiwan, New Zealand, Spain
-
Clovis Oncology, Inc.TerminatedSmall Cell Lung Cancer | Non-Small Cell Lung Cancer | NSCLC | Lung Cancer | Metastatic Lung Cancer | SCLC | Stage IV Lung Cancer | Advanced Lung Cancer | Squamous Non-Small Cell Lung CancerUnited States, Italy, Germany, France, Spain
-
GlaxoSmithKlineCompletedNon-Small Cell Lung Cancer | Lung Cancer, Non-Small CellUnited States, Spain, Israel
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerSpain, Netherlands, Austria, Greece, Germany, Italy
-
SanofiCompletedNon-small Cell Lung Cancer Stage IVSpain, France, Germany, Italy, United Kingdom
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerMexico, Italy, Australia, Spain
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerTaiwan, Spain, Italy, United States, Korea, Republic of, France
-
AstraZenecaCompletedNon Small Cell Lung CancerSpain, United Kingdom, France, United States
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerSpain, Italy, Germany, France
-
Fundación GECPRecruitingNon-small Cell Lung Cancer Stage III | KRAS P.G12CSpain
-
Novartis PharmaceuticalsRecruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Spain, Japan, Germany, Switzerland
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States
-
Spanish Lung Cancer GroupCompletedNon Small Cell Lung CancerSpain
-
TakedaCompletedNon-small Cell Lung Cancer (NSCLC)Spain
-
Fundación GECPActive, not recruiting